| Lynn G Howard, APRN CNP | |
|
100 Foden Road, West, Suite 100, South Portland, ME 04106 | |
| (207) 523-3904 | |
| (207) 523-8588 |
| Full Name | Lynn G Howard |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 100 Foden Road, West, South Portland, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184624397 | NPI | - | NPPES |
| 258830099 | Medicaid | ME | |
| 30348011 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | CNP81025 (Maine) | Primary |
| Entity Name | Mainegeneral Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669423380 PECOS PAC ID: 1254245715 Enrollment ID: O20031118000718 |
News Archive
In the first study, French scientists looked at neonatal outcome in terms of mode of delivery, gestational age, preterm birth rate (less than 37 weeks of gestation), mean child measurements, low birth weight (less than 2,500g) and perinatal mortality. When comparing the cryo singletons to the fresh cohort, the scientists showed that mean birth weight, mean height and head circumference were lower in the fresh population.
Where you live can increase your risk for experiencing delirium after surgery. So said a study that showed older adults who live in the most disadvantaged neighborhoods are two times more likely to experience delirium after surgery than their counterparts from more affluent communities.
Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable genetic disease called familial adenomatous polyposis.
Despite sluggish economic growth and rapidly rising health care costs, Americans' access to needed medical care improved slightly between 2001 and 2003, especially among low-income children and adults, according to a national study released today by the Center for Studying Health System Change (HSC).
Synthego, a leading provider of genome engineering solutions, officially launches today. Synthego's flagship product line, CRISPRevolution, features synthetic guide RNA products designed to accelerate CRISPR/Cas9 and Cpf1 genome engineering research. CRISPRevolution is the first product line to offer economical access to fully synthetic RNA for high fidelity editing and increased precision in genome editing.
› Verified 4 days ago
| Entity Name | Drynachan Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891044657 PECOS PAC ID: 2264718824 Enrollment ID: O20170826000019 |
News Archive
In the first study, French scientists looked at neonatal outcome in terms of mode of delivery, gestational age, preterm birth rate (less than 37 weeks of gestation), mean child measurements, low birth weight (less than 2,500g) and perinatal mortality. When comparing the cryo singletons to the fresh cohort, the scientists showed that mean birth weight, mean height and head circumference were lower in the fresh population.
Where you live can increase your risk for experiencing delirium after surgery. So said a study that showed older adults who live in the most disadvantaged neighborhoods are two times more likely to experience delirium after surgery than their counterparts from more affluent communities.
Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable genetic disease called familial adenomatous polyposis.
Despite sluggish economic growth and rapidly rising health care costs, Americans' access to needed medical care improved slightly between 2001 and 2003, especially among low-income children and adults, according to a national study released today by the Center for Studying Health System Change (HSC).
Synthego, a leading provider of genome engineering solutions, officially launches today. Synthego's flagship product line, CRISPRevolution, features synthetic guide RNA products designed to accelerate CRISPR/Cas9 and Cpf1 genome engineering research. CRISPRevolution is the first product line to offer economical access to fully synthetic RNA for high fidelity editing and increased precision in genome editing.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lynn G Howard, APRN CNP 100 Gannett Drive, Suite C, South Portland, ME 04106-5900 Ph: (207) 828-0361 | Lynn G Howard, APRN CNP 100 Foden Road, West, Suite 100, South Portland, ME 04106 Ph: (207) 523-3904 |
News Archive
In the first study, French scientists looked at neonatal outcome in terms of mode of delivery, gestational age, preterm birth rate (less than 37 weeks of gestation), mean child measurements, low birth weight (less than 2,500g) and perinatal mortality. When comparing the cryo singletons to the fresh cohort, the scientists showed that mean birth weight, mean height and head circumference were lower in the fresh population.
Where you live can increase your risk for experiencing delirium after surgery. So said a study that showed older adults who live in the most disadvantaged neighborhoods are two times more likely to experience delirium after surgery than their counterparts from more affluent communities.
Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable genetic disease called familial adenomatous polyposis.
Despite sluggish economic growth and rapidly rising health care costs, Americans' access to needed medical care improved slightly between 2001 and 2003, especially among low-income children and adults, according to a national study released today by the Center for Studying Health System Change (HSC).
Synthego, a leading provider of genome engineering solutions, officially launches today. Synthego's flagship product line, CRISPRevolution, features synthetic guide RNA products designed to accelerate CRISPR/Cas9 and Cpf1 genome engineering research. CRISPRevolution is the first product line to offer economical access to fully synthetic RNA for high fidelity editing and increased precision in genome editing.
› Verified 4 days ago
Mr. Michael Urban Trueworthy, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 650 Main St, Ste 213, South Portland, ME 04106 Phone: 207-835-6098 Fax: 207-835-6097 | |
Mary P Delois, RN,MSN,F.N.P.-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 260 Western Ave, South Portland, ME 04106 Phone: 207-761-4700 Fax: 207-761-4744 | |
Pamela G. Argereow, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 Foden Road, West, Suite 100, South Portland, ME 04106 Phone: 207-523-3904 Fax: 207-523-8588 | |
Meredith L Curtis, AG PCNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 265 Western Ave Ste 2, South Portland, ME 04106 Phone: 207-661-0200 | |
Ms. Melissa Nye Libby, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Brickhill Ave, Ste 304, South Portland, ME 04106 Phone: 207-761-4700 Fax: 207-467-8910 | |
Mr. Duncan T Hopkins Jr., MS, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 209 Western Ave, Suite B2, South Portland, ME 04106 Phone: 207-553-9071 Fax: 207-553-9074 | |
Samantha R. Reilly, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 Foden Rd East, Ste 203, South Portland, ME 04106 Phone: 207-874-1489 Fax: 207-523-8590 |